Dr. Arash Moradzadeh, MD

Dr. Moradzadeh practices at Beverly Hills Endoscopy in Beverly Hills, California.

Dr. Moradzadeh's NPI, 1306930821, was assigned on October 2, 2006. Dr. Moradzadeh graduated from UC San Diego School of Medicine in 2003. Dr. Moradzadeh holds California license A115132.

Dr. Moradzadeh's primary practice is Beverly Hills Endoscopy, at 8920 Wilshire Boulevard, Suite 320, Beverly Hills, CA 90211. The practice phone is (310) 888-8898.

Dr. Moradzadeh's primary practice is Beverly Hills Endoscopy in Beverly Hills, California. Dr. Moradzadeh is also affiliated with Cedars-Sinai Medical Center. Dmand AI also links Dr. Moradzadeh to 2 more physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moradzadeh practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Dr. Moradzadeh's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Dr. Moradzadeh is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Moradzadeh's licenses on file in 2 states: California and Missouri.

CMS data shows 666 Medicare services from Dr. Moradzadeh across 8 procedure codes in 2024, for 243 Medicare patients. Medicare paid $46,227 for them. Every service was in an office.

CMS counts 243 Medicare patients who saw Dr. Moradzadeh in 2024. The largest group is 75 to 84, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moradzadeh's median patient age at 70, with 58% women.

In 2024, Dr. Moradzadeh wrote 317 Medicare Part D claims for 130 patients. 92% of them were for generic drugs. CMS names the drug for 212 of them, across 11 drugs with 11 or more claims each, at $8,273 in total drug cost. In 2023, CMS named 162 claims across 9 drugs.

Dr. Moradzadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Moradzadeh, published from 2007 to 2013. 2008 was the busiest year, with 3. The most frequent topics are Nerve Regeneration, Rats, Inbred Lew and Peripheral Nerves. Dr. Moradzadeh has published most often in Exp Neurol. Dr. Moradzadeh's most frequent co-authors are Elizabeth Louisa Whitlock, MD and Allen Brent Mendez, MD.

CMS Open Payments shows 283 general payments to Dr. Moradzadeh from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Allergan Inc. paid the most, $7,096.

Dmand AI lists 15 awards for Dr. Moradzadeh, most recently CMS Stage 1 EHR in 2013.

Dr. Moradzadeh graduated from UC San Diego School of Medicine in 2003.

Dr. Moradzadeh is in network with 6 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.